Wyss InstitutePersonalized Medicine – Wyss Institute

Wyss Institute receives Massachusetts Life Science Center award to advance metabolomics and lipidomics research across Massachusetts ecosystem

Jessica Leff — Wed, 22 Jul 2026 14:03:23 +0000

By Benjamin Boettner (BOSTON) — The Wyss Institute at Harvard University has received an award from the Massachusetts Life Science Center (MLSC), enabling it to host a next-generation metabolomics and lipidomics analytical platform. The platform will allow its researchers to creatively pursue new approaches to biomarker and drug discovery across multiple health challenges the Institute is…

Source

Recapitulating intramuscular vaccination with mRNA vaccines in patient-specific Lymphoid Organ Chips

Mariel Schoen — Fri, 17 Jul 2026 13:55:40 +0000

By Benjamin Boettner (BOSTON) — The protective abilities of the Moderna and BioNTech mRNA vaccines developed against COVID-19 saved millions of lives during the pandemic and put this platform technology in the spotlight of vaccine research. By now, mRNA vaccines for other infectious diseases, such as influenza, RSV, and HIV are being tested in clinical trials and highly anticipated.

Source

The Wyss Institute’s 2026-2027 Validation Projects

Jessica Leff — Mon, 06 Jul 2026 14:00:41 +0000

Each year, the Wyss Institute’s Validation Project program identifies technologies that are ready to move beyond discovery and into the validation phase. Through dedicated funding, technical resources, business development support, market research, and engagement with clinicians, investors, industry experts, and key opinion leaders, the program helps research teams de-risk high-impact innovations…

Source

David Chou on keeping people safe from radiation on Earth and beyond

Jessica Leff — Thu, 28 May 2026 13:00:27 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. David Chou’s work is literally out of this world! In addition to identifying radiation countermeasures for use on Earth, he is part of the AVATAR project, which aims to understand how humans…

Source

Next-Gen Toxicology: Inside the Organ Chip Revolution with Donald Ingber

Jessica Leff — Wed, 06 May 2026 17:06:35 +0000

In this episode of ToxChats, hosts Lauren Walker and Sarah Benjamin sit down with the groundbreaking Donald Ingber—visionary scientist, engineer, and Founding Director of the Wyss Institute. Ingber shares how his unique path through medicine, biology, and design converged to spark breakthroughs such as human Organ Chips—systems that are redefining toxicology, drug development, and disease modeling.

Source

Ultrasensitive test detects biomarkers for specific form of dementia

Mariel Schoen — Tue, 05 May 2026 13:55:08 +0000

By MGB Communications (BOSTON) — Dementia affects over 57 million people worldwide, a number expected to nearly double in the next 20 years. This permanent loss of cognitive abilities affects daily function and can be caused by multiple brain pathologies, including well known ones like Alzheimer’s disease (AD). Right now, biomarkers permit diagnosis of AD but not rarer pathologies like…

Source

Wyss Institute technologies enable breakthrough in astronaut health research aboard NASA’s Artemis II mission

Jessica Leff — Thu, 09 Apr 2026 14:55:20 +0000

By Alexandra Jirstrand (BOSTON) – Launched on April 1, 2026, Artemis II is a historic, approximately 10-day lunar flyby mission that is sending four astronauts farther into space than any humans have traveled since the Apollo era, marking a critical step toward sustained lunar exploration and future missions to Mars. The Wyss Institute for Biologically Inspired Engineering at Harvard…

Source

Toward autonomous self-organizing biological robots with a nervous system

Mariel Schoen — Mon, 16 Mar 2026 18:30:42 +0000

By Benjamin Boettner (BOSTON) — Biobots, whose growing line of variants started with Xenobots, are fascinating tiny self-powered living robots built exclusively using frog embryonic cells. Originally developed in the laboratories of Wyss Institute Associate Faculty member and Tufts University Professor Michael Levin, Ph.D. and his collaborators at University of Vermont…

Source

Transforming cancer treatments through bioinspired engineering and translation

Jessica Leff — Wed, 04 Feb 2026 14:59:03 +0000

Despite major advances in personalized medicine, targeted drugs, and immunotherapies, many cancers remain difficult – or impossible – to treat. Even when therapies work, they can trigger serious secondary health risks that may themselves become life-threatening. Wyss Institute researchers are tackling these challenges head-on by developing new therapies that more powerfully activate the immune…

Source

A CRISPR fingerprint of pathogenic C. auris fungi

Jessica Leff — Wed, 14 Jan 2026 13:45:36 +0000

By Benjamin Boettner (BOSTON) — Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and residents of nursing homes, especially those who are already weakened by other illnesses. The pathogen easily spreads and colonizes surfaces and objects where it can survive for weeks to months, and is often resistant to standard…

Source